UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

The New England journal of medicine, 2009-09, Vol.361 (10), p.958-967

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3337-3344

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer

International journal of gynecological cancer, 2019-07, Vol.29 (6), p.1050-1056

2019

Link zum Volltext

Verfügbarkeit prüfen

Laparoscopic Treatment and Staging of Early Ovarian Cancer

Journal of minimally invasive gynecology, 2008-07, Vol.15 (4), p.414-419

2008

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer

Journal of clinical oncology, 2018-05, Vol.36 (13), p.1300-1307

2018

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

The lancet oncology, 2012-03, Vol.13 (3), p.239-246

2012

Link zum Volltext

Verfügbarkeit prüfen

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

British journal of cancer, 2023-04, Vol.128 (8), p.1503-1513

2023

Link zum Volltext

Verfügbarkeit prüfen

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

The New England journal of medicine, 2016-12, Vol.375 (22), p.2154-2164

2016

Link zum Volltext

Verfügbarkeit prüfen

Infection of reservoir-central venous catheter by Leclercia adecarboxylata in a patient with Ewing sarcoma

Medicina clínica, 2010-05, Vol.134 (14), p.660-661

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC)‏ (GEICO 1205/NOVA TRIAL)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5508-5508

2017

Link zum Volltext

Verfügbarkeit prüfen

ENGAGE: Evaluation of a streamlined oncologist-led BRCA mutation ( BRCA m) testing and counselling model for patients with ovarian cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5559-5559

2017

Link zum Volltext

Verfügbarkeit prüfen

CD8 + TILs in early stage epithelial ovarian cancer: A GEICO study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5543-5543

2017

Link zum Volltext

Verfügbarkeit prüfen

Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5577-5577

2017

Link zum Volltext

Verfügbarkeit prüfen

Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study—GETHI 2013-01

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS5612-TPS5612

2015

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07

Anticancer research, 2016-12, Vol.36 (12), p.6647-6654

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma : A study by the Spanish group for research on sarcomas

Cancer, 2005-10, Vol.104 (8), p.1706-1712

2005

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of fixed-dosed rate gemcitabine in platinum-resistant ovarian cancer: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) Trial

American journal of clinical oncology, 2008-10, Vol.31 (5), p.481-487

2008

Link zum Volltext

Verfügbarkeit prüfen

Exosomes isolation and characterization in non small cell lung carcinoma patients: Proof of concept study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.11101-11101

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC) (GEICO 1205/NOVA TRIAL)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5531-5531

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Humans
(39)
Life Sciences & Biomedicine
(39)
Female
(29)
Male
(20)
Middle Aged
(20)
Aged
(19)
Oncology
(18)
Adult
(14)
Aged, 80 And Over
(9)
Lung Neoplasms - Drug Therapy
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Chemotherapy
(7)
Chronic Kidney Disease
(7)
Ovarian Neoplasms - Drug Therapy
(7)
Patients
(7)
Treatment Outcome
(7)
Tumors
(7)
Biological And Medical Sciences
(6)
Disease-Free Survival
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial

Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer

Laparoscopic Treatment and Staging of Early Ovarian Cancer

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial

Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE)

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03

Infection of reservoir-central venous catheter by Leclercia adecarboxylata in a patient with Ewing sarcoma

Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC)‏ (GEICO 1205/NOVA TRIAL)

ENGAGE: Evaluation of a streamlined oncologist-led BRCA mutation ( BRCA m) testing and counselling model for patients with ovarian cancer

CD8 + TILs in early stage epithelial ovarian cancer: A GEICO study

Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study

Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study—GETHI 2013-01

Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07

A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma : A study by the Spanish group for research on sarcomas

A phase II trial of fixed-dosed rate gemcitabine in platinum-resistant ovarian cancer: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) Trial

Exosomes isolation and characterization in non small cell lung carcinoma patients: Proof of concept study

Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC) (GEICO 1205/NOVA TRIAL)

Suchergebnisse filtern